These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7771610)

  • 1. Antimony oxidation states in antileishmanial drugs.
    Franco MA; Barbosa AC; Rath S; Dorea JG
    Am J Trop Med Hyg; 1995 May; 52(5):435-7. PubMed ID: 7771610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speciation of antimony (III) and antimony (V) using hydride generation for meglumine antimoniate pharmaceutical formulations quality control.
    Cabral LM; Juliano VN; Dias LR; Dornelas CB; Rodrigues CR; Villardi M; Castro HC; Santos TC
    Mem Inst Oswaldo Cruz; 2008 Mar; 103(2):130-7. PubMed ID: 18425264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
    Dzamitika SA; Falcão CA; de Oliveira FB; Marbeuf C; Garnier-Suillerot A; Demicheli C; Rossi-Bergmann B; Frézard F
    Chem Biol Interact; 2006 Apr; 160(3):217-24. PubMed ID: 16524568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime).
    Roberts WL; McMurray WJ; Rainey PM
    Antimicrob Agents Chemother; 1998 May; 42(5):1076-82. PubMed ID: 9593130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.
    Borborema SE; Osso Junior JA; Andrade Junior HF; Nascimento Nd
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):196-203. PubMed ID: 27192589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
    Mandal G; Mandal S; Sharma M; Charret KS; Papadopoulou B; Bhattacharjee H; Mukhopadhyay R
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003500. PubMed ID: 25714343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpectedly high levels of antimony (III) in the pentavalent antimonial drug Glucantime: insights from a new voltammetric approach.
    Salaün P; Frézard F
    Anal Bioanal Chem; 2013 Jun; 405(15):5201-14. PubMed ID: 23612869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate.
    Frézard F; Demicheli C; Ferreira CS; Costa MA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):913-6. PubMed ID: 11181379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimony determination in tissues and serum of hamsters infected with Leishmania garnhami and treated with meglumine antimoniate.
    Lugo de Yarbuh A; Añez N; Petit de Peña Y; Burguera JL; Burguera M
    Ann Trop Med Parasitol; 1994 Feb; 88(1):37-41. PubMed ID: 8192513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physico-chemical characterization of meglumine antimoniate.
    Demicheli C; de Figueiredo TL; Carvalho S; Sinesterra RD; Lopes JC; Frézard F
    Biometals; 1999 Mar; 12(1):63-6. PubMed ID: 10420575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel methods for the encapsulation of meglumine antimoniate into liposomes.
    Frézard F; Michalick MS; Soares CF; Demicheli C
    Braz J Med Biol Res; 2000 Jul; 33(7):841-6. PubMed ID: 10881061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
    Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
    Chulay JD; Fleckenstein L; Smith DH
    Trans R Soc Trop Med Hyg; 1988; 82(1):69-72. PubMed ID: 2845611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physico-chemical characteristics of meglumine antimoniate in different storage conditions].
    Romero GA; de Oliveira MR; Correia D; Marsden PD
    Rev Soc Bras Med Trop; 1996; 29(5):461-5. PubMed ID: 8966310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
    Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
    Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH.
    dos Santos Ferreira C; de Castro Pimenta AM; Demicheli C; Frézard F
    Biometals; 2006 Oct; 19(5):573-81. PubMed ID: 16937264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speciation of antimony in injectable drugs used for leishmaniasis treatment (Glucantime®) by HPLC-ICP-MS and DPP.
    Séby F; Gleyzes C; Grosso O; Plau B; Donard OF
    Anal Bioanal Chem; 2012 Dec; 404(10):2939-48. PubMed ID: 23052871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal function in patients with mucocutaneous leishmaniasis treated with pentavalent antimony compounds].
    Veiga JP; Rosa TT; Kimachi T; Wolff ER; Sampaio RN; Gagliardi AR; Junqueira Júnior LF; Costa JM; Marsden PD
    Rev Inst Med Trop Sao Paulo; 1985; 27(6):298-302. PubMed ID: 3014634
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo antileishmanial properties of pentavalent antimonial compounds.
    Neal RA; Matthews PJ
    Trans R Soc Trop Med Hyg; 1982; 76(2):284. PubMed ID: 6285557
    [No Abstract]   [Full Text] [Related]  

  • 20. New insights into the chemical structure and composition of the pentavalent antimonial drugs, meglumine antimonate and sodium stibogluconate.
    Frézard F; Martins PS; Barbosa MC; Pimenta AM; Ferreira WA; de Melo JE; Mangrum JB; Demicheli C
    J Inorg Biochem; 2008 Apr; 102(4):656-65. PubMed ID: 18061680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.